Calculus Capital, an EIS and VCT institutional investor, has participated in a £7m new investment round led by Gresham House Ventures, a growth equity investor, alongside existing shareholders.
eConsult works as a digital gateway to a GP practice, allowing clinicians to determine the right care pathway more efficiently for patients, benefiting the GP practices by releasing capacity and reducing costs. eConsult is driven by a proprietary, clinician led bank of 10,000+ questions produced using evidence-based medicine, NICE guidance, Clinical Knowledge Summaries and NHS.UK sources.
It efficiently records patient details, case history, symptoms, and provides them to the GP in a concise format where they are processed in 2-3 minutes. Research shows that 70% of requests are closed without the need for a face-to-face appointment.
Rapid adoption of eConsult’s solution has been aided by the introduction of centralised government funding for online consultation in 2016 and more recently the COVID-19 pandemic has dramatically increased the need for digital triage systems leading to an acceleration in uptake.
Dr Murray Ellender, CEO of eConsult Health, commented: “This funding will help us keep pace with the product development we need to support cutting edge health technology across both primary and secondary care. NHS patients deserve an excellent digital experience when interacting with the health service and we now look forward to delivering the transformation needed.”
Henry Alty, Investment Director at Gresham House Ventures said: “At such a crucial moment for healthcare provision, funding the right businesses in this space is more important than ever. The eConsult platform has already proven the power of its clinically led technology, as the most widely used digital consultation solution and the first choice for NHS GP surgeries.”